Chlorhexidine gluconate - Dexcel Pharma

Drug Profile

Chlorhexidine gluconate - Dexcel Pharma

Alternative Names: Chlorhexidine gluconate chip; PerioChip

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dexcel-Pharma
  • Class Anti-infectives; Antiseptics; Biguanides; Small molecules
  • Mechanism of Action Bacterial capsule modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Periodontitis
  • Phase III Peri-implantitis

Most Recent Events

  • 06 Sep 2017 Chlorhexidine gluconate is still in a phase III trial for Peri-implantitis in Germany, Israel, USA and United Kingdom (NCT02080403)
  • 01 Jul 2014 Phase-III clinical trials in Peri-implantitis in Germany (Subgingival)
  • 01 Jul 2014 Phase-III clinical trials in Peri-implantitis in Israel (Subgingival)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top